AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Wainua (eplontersen) — Worldwide product sales by Quarter
Wainua (eplontersen) — Worldwide product sales ($M) ($M)
AstraZeneca Wainua (eplontersen) — Worldwide product sales: $70M in Q2 2026, up 59.1% from a year earlier. That is the highest of the 10 quarters on record here.
Where the Q2 2026 figure comes from
“|| Wainua | | 70 | | 58 | | 58 | | 64 | | 50 | | 1 | | n/m | | n/m | | 4 | | n/m | | n/m | | 1 | | n/m | | n/m”
Source: Form 6-K FY2026Q2 Earnings Release ↗
Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Wainua (eplontersen) — Worldwide product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 70 | +59.1% | Form 6-K FY2026Q2 Earnings Release ↗ |
| Q1 2026 | Mar 31, 2026 | 51 | +30.8% | Form 6-K FY2026Q1 Earnings Release ↗ |
| Q4 2025 | Dec 31, 2025 | 69 | +64.3% | Form 6-K FY2025Q4 Earnings Release ↗ |
| Q3 2025 | Sep 30, 2025 | 59 | +156.5% | Form 6-K FY2025Q3 Earnings Release ↗ |
| Q2 2025 | Jun 30, 2025 | 44 | +175.0% | Form 6-K FY2025Q2 Earnings Release ↗ |
| Q1 2025 | Mar 31, 2025 | 39 | +680.0% | Form 6-K FY2025Q1 Earnings Release ↗ |
| Q4 2024 | Dec 31, 2024 | 42 | – | Form 6-K FY2024Q4 Earnings Release ↗ |
| Q3 2024 | Sep 30, 2024 | 23 | – | Form 6-K FY2024Q3 Earnings Release ↗ |
| Q2 2024 | Jun 30, 2024 | 16 | – | Form 6-K FY2024Q2 Earnings Release ↗ |
| Q1 2024 | Mar 31, 2024 | 5 | – | Form 6-K FY2024Q1 Earnings Release ↗ |
Breakdown
What makes up wainua (eplontersen) — Worldwide product sales
- Wainua (eplontersen) — Worldwide YoY actual (%)58.0% · Q2 2026
- Wainua (eplontersen) — Worldwide YoY CER (%)58.0% · Q2 2026
- Wainua (eplontersen) — US product sales ($M)64 · Q2 2026
- Wainua (eplontersen) — Emerging Markets product sales ($M)1 · Q2 2026
- Wainua (eplontersen) — Europe product sales ($M)4 · Q2 2026
- Wainua (eplontersen) — Established RoW product sales ($M)1 · Q2 2026
Cite this data
StockData. (2026). AstraZeneca Wainua (eplontersen) — Worldwide product sales ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-wainua-world
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.